Sources

12 Total Sources

Hims Shares Tumble After 37-Cent Loss Swamps Q2 Sales Beat

Left17%

Center33%

Right33%

Far Right17%

Investor's Business Daily10d ago

Hims Stock Falls After Reporting 37-Cent Per-Share Loss

Hims & Hers' shift to branded obesity drugs drives wider quarterly loss | Reuters

BNN Bloomberg10d ago

Hims & Hers shares slide

Barron's10d ago

Hims Stock Falls on Earnings. Why a Guidance Hike Isn't Enough. - Barron's

scanx.trade10d ago

Hims & Hers Health Q3 Results: Sales beat estimates with $880M-$900M guidance

Hims Q2 Revenue Beat, but a 38% Growth Spurt Isn't Enough If Margins Keep Falling

The Wall Street Journal10d ago

Hims & Hers Health Raises Revenue Outlook - WSJ

Stocktwits9d ago

HIMS Retail Traders Flip Bullish After Q2 Print: Hims & Hers Keeps $225M Buyback Ready For Stock 'Disconnect'

Hims & Hers stock drops 7% despite higher guidance: what went wrong?

Facebook10d ago

Marley Kayden and Sam Vadas break down Hims & Hers Health (HIMS) and Rocket Lab's (RKLB) second-quarter earnings reports, guidance, and what they're anticipating hearing going forward., For more ...

Rocket Lab Falls, Hims Declines, Nvidia Announces Partnership with Wall Street Banks | Stock Movers

Benzinga10d ago

Hims & Hers Shares Drop After Mixed Q2 Earnings — Details - Hims & Hers Health (NYSE:HIMS) - Benzinga